Gut⁻Liver Axis: How Do Gut Bacteria Influence the Liver?
- PMID: 30227645
- PMCID: PMC6165386
- DOI: 10.3390/medsci6030079
Gut⁻Liver Axis: How Do Gut Bacteria Influence the Liver?
Abstract
Chronic liver diseases are a major cause of morbidity and mortality worldwide. Recently, gut dysbiosis was identified as an important factor in the pathogenesis of liver diseases. The relationship between gut microbiota and the liver is still not well understood; however, dysfunction of the gut mucosal barrier ("leaky gut") and increased bacterial translocation into the liver via the gut⁻liver axis probably play crucial roles in liver disease development and progression. The liver is an important immunological organ, and, after exposure to gut-derived bacteria via portal circulation, it responds with activation of the innate and adaptive immune system, leading to hepatic injury. A better understanding of the pathophysiological links among gut dysbiosis, the integrity of the gut barrier, and the hepatic immune response to gut-derived factors is essential for the development of new therapies to treat chronic liver diseases.
Keywords: chronic liver diseases; dysbiosis; gut microbiota.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Gut-liver axis signaling in portal hypertension.World J Gastroenterol. 2019 Oct 21;25(39):5897-5917. doi: 10.3748/wjg.v25.i39.5897. World J Gastroenterol. 2019. PMID: 31660028 Free PMC article. Review.
-
The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases.Int J Biol Sci. 2020 Jun 23;16(13):2357-2366. doi: 10.7150/ijbs.46405. eCollection 2020. Int J Biol Sci. 2020. PMID: 32760203 Free PMC article. Review.
-
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.Hepatol Int. 2018 Feb;12(Suppl 1):24-33. doi: 10.1007/s12072-017-9798-x. Epub 2017 May 26. Hepatol Int. 2018. PMID: 28550391 Free PMC article.
-
Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.J Hepatol. 2018 Oct;69(4):886-895. doi: 10.1016/j.jhep.2018.05.021. Epub 2018 May 25. J Hepatol. 2018. PMID: 29803899 Free PMC article.
-
Starring role of toll-like receptor-4 activation in the gut-liver axis.World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):99-109. doi: 10.4291/wjgp.v6.i4.99. World J Gastrointest Pathophysiol. 2015. PMID: 26600967 Free PMC article.
Cited by
-
A microencapsulated blend of botanicals supports weaning piglets during a lipopolysaccharide challenge by modulating liver inflammation and intestinal integrity.J Anim Sci. 2024 Jan 3;102:skae277. doi: 10.1093/jas/skae277. J Anim Sci. 2024. PMID: 39289925 Free PMC article.
-
Better detoxifying effect of ripe forsythiae fructus over green forsythiae fructus and the potential mechanisms involving bile acids metabolism and gut microbiota.Front Pharmacol. 2022 Aug 12;13:987695. doi: 10.3389/fphar.2022.987695. eCollection 2022. Front Pharmacol. 2022. PMID: 36034807 Free PMC article.
-
Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases.Int J Mol Sci. 2021 Dec 31;23(1):426. doi: 10.3390/ijms23010426. Int J Mol Sci. 2021. PMID: 35008852 Free PMC article. Review.
-
Recent advances in alcoholic hepatitis.F1000Res. 2020 Feb 10;9:F1000 Faculty Rev-97. doi: 10.12688/f1000research.20394.1. eCollection 2020. F1000Res. 2020. PMID: 32089834 Free PMC article. Review.
-
Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma.Oncotarget. 2021 Nov 23;12(24):2421-2433. doi: 10.18632/oncotarget.28077. eCollection 2021 Nov 23. Oncotarget. 2021. PMID: 34853663 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources